RMBL:US
$39.43
-1.029%
TG Therapeutics Inc.Key Data
Last updated: Jun 10, 2025, 8:54 PM ET
Price Metrics
- Open39.81
- Close39.43
- Prev. Close39.84
- Day High/Low40.40/39.141
- 52 Week High/Low46.48/15.16
- Alpha0.019
- Beta1.938
- VWAP39.691
Moving Averages
- 21 Day Moving Average35.819
- 50 Day Moving Average37.447
- 200 Day Moving Average31.629
Valuation Metrics
- Market Cap (All Classes)6,259,711,070.00
- Market Cap6,259,711,070.00
- EPS (TTM)0.15
- P/E Ratio (TTM)442.67
- P/B Ratio26.65
- P/CF Ratio-55.10
- D/E Ratio—
- Return on Equity—
- Return on Assets—
Share Statistics
- Total Shares (All Classes)158,755,036.00
- Listed Shares Outstanding158,755,036.00
- Escrow Shares—
- Volume1,530,770.00
- 10 Day Avg Vol.1,691,788.00
- 20 Day Avg Vol.1,747,370.00
- 30 Day Avg Vol.2,584,794.00
- 50 Day Avg Vol.2,694,426.00
Dividends
- Dividend—
- Dividend Frequency—
- Dividend Yield (Ann)—
- Ex-Date—
- Payable date—
- Dividend Growth (3 Year)—
- Dividend Growth (5 Year)—
Short Interest (as of Jun 11, 2025)
- Short Interest as % of Float-%
- Short Interest Days to Cover-